| Product Name | MF | CAS | Details |
|---|
| Methylmalonate | C4H6O4 | 516-05-2 | Details |
| MK 2206 dihydrochloride | C25H22ClN5O | 1032350-13-2 | Details |
| MERS-CoV 3CL Protease (YP_009047217.1) VersaClone cDNA | Details |
| ML 281 | C22H19N3O2S | 1404437-62-2 | Details |
| ML 184 | C25H34N4O3S | 794572-10-4 | Details |
| MERS-CoV Spike RBD AlexaFluor488-conjugated Antibody | Details |
| MERS-CoV Spike RBD AlexaFluor594-conjugated Antibody | Details |
| Minoxidil | C9H15N5O | 38304-91-5 | Details |
| MK 1903 | C8H8N2O2 | 1268882-43-4 | Details |
| Methysergide maleate | C25H31N3O6 | 129-49-7 | Details |
| ML 179 | C21H25F3N4O2 | 1883548-87-5 | Details |
| ML 218 hydrochloride | C19H27Cl3N2O | 2319922-08-0 | Details |
| Metoprolol tartrate | 2C15H25NO3.C4H6O6 | 56392-17-7 | Details |
| MK 0677 | C28H40N4O8S2 | 159752-10-0 | Details |
| MERS-CoV Spike RBD AlexaFluor750-conjugated Antibody | Details |
| ML 162 | C23H22Cl2N2O3S | 1035072-16-2 | Details |
| Mirtazapine | C17H19N3 | 85650-52-8 | Details |
| MERS-CoV Nucleocapsid Antibody | Details |
| Mevastatin | C23H34O5 | 73573-88-3 | Details |
| Mito-HE | C43H43IN3P | 1003197-00-9 | Details |
| Mirabegron | C21H24N4O2S | 223673-61-8 | Details |
| Methotrexate | C20H22N8O5 | 59-05-2 | Details |
| MERS-CoV Spike RBD Antibody | Details |
| ML 277 | C23H25N3O4S2 | 1401242-74-7 | Details |
| MG 132 | C26H41N3O5 | 133407-82-6 | Details |
| MK 386 | C28H49NO | 158493-17-5 | Details |
| MERS-CoV Spike Protein (YP_007188579.1) VersaClone cDNA | Details |
| ML 335 | C15H14Cl2N2O3S | 825658-06-8 | Details |
| Mexiletine hydrochloride | C11H18ClNO | 5370-01-4 | Details |
| ML 133 hydrochloride | C19H20ClNO | 1222781-70-5 | Details |
| Mifepristone | C29H35NO2 | 84371-65-3 | Details |
| Methylcellulose Stock Solution | Details |
| ML 299 | C23H26BrFN4O2 | 1426916-00-8 | Details |
| Miglustat hydrochloride | C10H22ClNO4 | 210110-90-0 | Details |
| MERS-CoV Nucleocapsid (YP_007188586.1) VersaClone cDNA | Details |
| MK6-83 | C16H20N2O2S2 | 1062271-24-2 | Details |
| Mitomycin C | C15H18N4O5 | 50-07-7 | Details |
| MK 886 | C27H34ClNO2S | 118414-82-7 | Details |
| Mithramycin A | C52H76O24 | 18378-89-7 | Details |
| Mesopram | C14H19NO4 | 189940-24-7 | Details |
| Methyllycaconitine citrate | C43H58N2O17 | 351344-10-0 | Details |
| MK 212 hydrochloride | C8H12Cl2N4 | 61655-58-1 | Details |
| MitoBrilliant 646 | Details |
| Mesulergine hydrochloride | C18H27ClN4O2S | 72786-12-0 | Details |
| ML 213 | C17H23NO | 489402-47-3 | Details |
| ML 323 | C23H24N6 | 1572414-83-5 | Details |
| ML 210 | C22H20Cl2N4O4 | 1360705-96-9 | Details |
| MI 14 | C19H23ClN6O3S | 1715934-43-2 | Details |
| MK 571 | C26H27ClN2O3S2 | 115104-28-4 | Details |
| Miro1 Reducer | C20H17ClFN7O | 2624336-91-8 | Details |
| MEM (Earle's salts), non-essential amino acids, no glutamine | Details |
| MERS-CoV Spike RBD AlexaFluor350-conjugated Antibody | Details |
| Methoxyluteolin | C19H18O6 | 855-97-0 | Details |
| ML 190 | C27H32N6O3 | 1355244-02-8 | Details |
| MES, free acid | C6H13NO4S | 4432-31-9 | Details |
| MKT 077 | C21H22ClN3OS2 | 147366-41-4 | Details |
| MitoBrilliant Live 549 | Details |
| Methylprednisolone | C22H30O5 | 83-43-2 | Details |
| MitoPY1 | C52H53BN2O5P+ | 1041634-69-8 | Details |
| ML 233 | C19H21NO4S | 2080311-92-6 | Details |
| Mepyramine maleate | C21H27N3O5 | 59-33-6 | Details |
| ML 339 | C26H32ClN3O5 | 2080300-49-6 | Details |
| MERS-CoV Spike RBD AlexaFluor647-conjugated Antibody | Details |
| ML 145 | C24H22N2O5S2 | 1164500-72-4 | Details |
| ML 221 | C17H11N3O6S | 877636-42-5 | Details |
| ML 239 | C13H10Cl3N3O2 | 1378872-36-6 | Details |
| ML 120B dihydrochloride | C19H16Cl2N4O2 | 1782573-78-7 | Details |
| MERS-CoV Spike RBD AlexaFluor405-conjugated Antibody | Details |
| ML 204 | C15H18N2 | 5465-86-1 | Details |
| ML 337 | C21H20FNO3 | 1443118-44-2 | Details |
| ML 334 | C26H26N2O5 | 1432500-66-7 | Details |
| MgATP Solution | Details |
| MERS-CoV Spike RBD MAb (Cl 1038342) | Details |
| MitoBrilliant Live 646 | Details |
| Metformin hydrochloride | C4H12ClN5 | 1115-70-4 | Details |
| Methylergometrine maleate | C24H29N3O6 | 57432-61-8 | Details |
| Minocycline hydrochloride | C23H28ClN3O7 | 13614-98-7 | Details |
| Mibefradil dihydrochloride | C29H40Cl2FN3O3 | 116666-63-8 | Details |
| MERS-CoV Spike RBD AlexaFluor700-conjugated Antibody | Details |
| ML 141 | C22H21N3O3S | 71203-35-5 | Details |
| ML 193 | C28H25N5O4S | 713121-80-3 | Details |
| ML 252 | C20H24N2O | 1392494-64-2 | Details |
| ML 347 | C22H16N4O | 1062368-49-3 | Details |
| Mirin | C10H8N2O2S | 1198097-97-0 | Details |
| ML 351 | C15H11N3O | 847163-28-4 | Details |
| Metastin (human) | C258H401N79O78 | 374683-24-6 | Details |
| Metyrapone | C14H14N2O | 54-36-4 | Details |
| ML 00253764 hydrochloride | C18H19BrClFN2O | 1706524-94-8 | Details |
| Milrinone | C12H9N3O | 78415-72-2 | Details |
| MEM (Earle's salts), 25 mM HEPES, non-essential amino acids, no glutamine, no phenol red | Details |
| MERS-CoV Spike S1 Subunit Antibody | Details |
| MI 2 (MALT1 inhibitor) | C19H17Cl3N4O3 | 1047953-91-2 | Details |
| Memantine hydrochloride | C12H22ClN | 41100-52-1 | Details |
| MIRA-1 | C8H9NO4 | 72835-26-8 | Details |
| ML 365 | C22H20N2O3 | 947914-18-3 | Details |
| ML 240 | C23H20N6O | 1346527-98-7 | Details |
| Methoxy-X04 | C23H20O3 | 863918-78-9 | Details |
| ML 315 hydrochloride | C18H13Cl2N3O2 | 1440251-53-5 | Details |
| ML 297 | C17H14F2N4O | 1443246-62-5 | Details |
| Methyl Green 1% | Details |
| Product Total： Product Page： | ||||
| 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 | ||||